supp.fit

Policosanol and Red Yeast Rice: study protocols

9 study groups took Policosanol together with Red Yeast Rice. These are the doses the studies gave. They are not a recommendation.

Policosanol: what the research found →

Dose per serving from research: Policosanol

9 study groups in 7 studies say how much Policosanol participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 5 mg to 10 mg, 100% of 9 study groups.

Daily doseStudy groups
5 mg to 10 mg
9

Dose per serving from research: Red Yeast Rice

9 study groups in 7 studies say how much Red Yeast Rice participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 100 mg to 250 mg, 89% of 9 study groups.

Daily doseStudy groups
50 mg or less
1
50 mg to 100 mg
0
100 mg to 250 mg
8

Commonly used together

8 of 9 study groups took Policosanol and Red Yeast Rice with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Berberine
7
Coenzyme Q10
3
Folic Acid
3

9 study groups

Study
Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment
2012 · BBR/P/RR monotherapy · Adults with primary polygenic hypercholesterolemia who were statin-intolerant or declined statin treatment
10 mg200 mg180 days152
Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment
2012 · Supplementary BBR/P/RR in HeFH patients on stable statin treatment or statin plus ezetimibe · Adults with genotype-confirmed heterozygous familial hypercholesterolemia on stable-dose statins or statins plus ezetimibe
10 mg200 mg90 days30
Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment
2012 · Combined BBR/P/RR plus ezetimibe therapy · Adults with primary hypercholesterolemia selected for a low response to monotherapy
10 mg200 mg90 days26
A Randomized, Double-Blinded, Placebo-Controlled, Clinical Study of the Effects of a Nutraceutical Combination (LEVELIP DUO(®)) on LDL Cholesterol Levels and Lipid Pattern in Subjects with Sub-Optimal Blood Cholesterol Levels (NATCOL Study)
2020 · LEVELIP DUO® · Adults aged 30–75 with moderately hypercholesterolemic, sub-optimal blood cholesterol levels, without other cardiovascular risk factors and not taking lipid-lowering drugs
10 mg5 mg8 weeks43
Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial
2015 · Combination A · Adults aged 18–70 with hypercholesterolemia not requiring statins or statin-intolerant
10 mg200 mg4 weeks23
The treatment of hypercholesterolemic children: efficacy and safety of a combination of red yeast rice extract and policosanols
2011 · Dietary supplement · Children aged 8–16 with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia
10 mg200 mg8 weeks40
Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study
2010 · nutraceutical combination (NC) · Adults with hypercholesterolemia; mean age 55 years; 26 males and 24 females were randomized across both arms
10 mg200 mg10 weeks25
Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trial
2014 · Intervention (Armolipid Plus/AP) · Men and women older than 18 years with mild-moderate hypercholesterolemia and elevated LDL-c, candidates for lifestyle intervention without hypolipemic drug treatment
10 mg200 mg12 weeks51
Effects of a New Combination of Medical Food on Endothelial Function and Lipid Profile in Dyslipidemic Subjects: A Pilot Randomized Trial
2019 · Nutraceutical B · Adults aged 18–75 with elevated serum cholesterol not requiring statins or statin-intolerant; people with cardiovascular disease and uncontrolled diabetes were excluded.
10 mg200 mg6 weeks23
Policosanol and Red Yeast Rice: study protocols | supp.fit